MedTrace Logo

Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

NCT06792292 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 765

Last updated 2025-01-24

No results posted yet for this study

Summary

Cancer can develop in the colon, or large bowel. Examination of the colon with a tube fitted with a camera is called a colonoscopy.

Colonoscopy allows detection of small growths in the colon, called "polyps". Polyps can often be removed during colonoscopy. Some of these polyps are called adenomas and can become cancer after several years.

A good colonoscopy aims to find and take out as many of these polyps as possible.

A quality indication of colonoscopy is the "adenoma detection rate" (ADR). It should be high, meaning many polyps are detected and taken out.

New artificial intelligence devices to assist colonoscopy seem to increase the ADR, and maybe help prevent cancer even better than normal colonoscopy.

The goal of this clinical trial is to compare the ADR when using standard colonoscopy to the ADR with artificial intelligence (AI)-assisted colonoscopy.

Conditions

  • Artificial Intelligence
  • Colonic Adenoma
  • Colonic Neoplasms
  • Colonic Polyp
  • Colonoscopy

Interventions

OTHER

conventional colonoscopy procedure

Study subjects in this interventional arm will undergo conventional colonoscopy.

OTHER

artificial intelligence-assisted colonoscopy procedure

Study subjects in this interventional arm will undergo colonoscopy done with a commercially-available module that uses artificial intelligence to highlight suspected polyps on the screen during colonoscopy. This module also attempts to characterize the detected polyp as adenomatous or not. The detection and characterization of polyps is in real time, during the procedure.

Sponsors & Collaborators

  • Chirec

    lead OTHER

Principal Investigators

  • Denis Franchimont, M.D., PhD · Chirec

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-12-31
Completion
2027-06-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06792292 on ClinicalTrials.gov